Reishi (Ganoderma lucidum) has been used in East Asian medicine for a very long time, and it's sold today for immunity, stress, sleep and the liver. It gets oversold by one side of the supplement industry and dismissed out of hand by the other. This edition sets out what has been tested in people, what has only been seen in the lab, and what has gone wrong.
What's in it
The evidence, by use
Fatigue and wellbeing
The strongest single trial: 132 Chinese adults diagnosed with neurasthenia (a diagnosis centred on fatigue, used more in China than in the UK) were randomised to a reishi polysaccharide extract (Ganopoly, 1,800 mg three times a day) or placebo for 8 weeks. Fatigue and overall severity improved more with reishi: 51.6% were rated more than minimally improved, against 24.6% on placebo (Tang 2005). A small pilot trial in 48 women with breast cancer on hormone therapy reported less fatigue after 4 weeks of spore powder (Zhao 2012). Grade: mixed. Two small trials, both of specific products, neither repeated in a UK-type population.
Alongside cancer treatment
A Cochrane review found five randomised trials, all of poor quality. Reishi given alongside chemotherapy or radiotherapy was associated with better tumour response and quality of life, and with small rises in some immune-cell counts. No trial measured survival, and the reviewers found no case for reishi as a first-line treatment (Jin 2016). An uncontrolled study in mixed advanced cancers reported higher NK-cell activity after 12 weeks (Gao 2003). The same team's later study in advanced lung cancer found no significant change in NK activity overall (Gao 2005). Grade: mixed, poor-quality trials. If you have cancer, it belongs only in a conversation with your oncology team.
Cholesterol, blood sugar and blood pressure
The lab finding that triterpenes act on the statin pathway hasn't translated in people. A Cochrane review of trials in people with type 2 diabetes found no meaningful effect on HbA1c, total or LDL cholesterol, triglycerides or blood pressure. Adverse events were somewhat more common on reishi, though none were serious (Klupp 2015). Grade: tested, and no benefit shown.
Stress, cortisol and sleep
Reishi prolonged sleep in rats (Cui 2012), and there are animal studies on the stress response. There are no randomised trials in people for sleep or for cortisol. Grade: mechanistic and untested. I previously described the sleep effect as "mild but consistent" in practice. That was my impression, not evidence, and I've removed it.
The liver: both directions
Animal studies report protective effects on the liver, and a 10-day study in 10 healthy volunteers found no harmful changes in the markers measured (Wachtel-Galor 2004). Grade for "hepatoprotective": animal only. Set against that, there are case reports of liver injury with reishi powder:
- Hong Kong (Yuen 2004);
- a fatal case of fulminant hepatitis in Thailand, in someone who switched from boiled reishi to powder (Wanmuang 2007);
- acute hepatitis after reishi powder taken with alcohol, which resolved after stopping (Guedikian 2023).
Case reports can't tell you how common this is. Several involved other medicines too. But they rule out calling reishi "liver support" without a warning. I no longer suggest reishi for raised liver enzymes or a raised GGT. Those need a GP to find the cause.
Choosing a product
If you decide to try it, the product matters, because most products on sale aren't what the trials used.
| Product type | Polysaccharides | Triterpenes | Matches a trial? |
|---|---|---|---|
| Fruiting body, hot water + alcohol extract | Yes | Yes | Closest to the general literature |
| Fruiting body, hot water only | Yes | Low | Closer to the polysaccharide trials |
| Mycelium grown on grain | Lower, plus grain starch | Low or variable | No |
| Spore powder | Lower | Higher | One pilot trial (Zhao 2012) |
Look for the species (Ganoderma lucidum), the part used (fruiting body or spores), the extraction method, and the beta-glucan and triterpene content per serving, plus a third-party test for heavy metals. I used to give minimum percentages here, but I can't point to a source for them, so I've taken them out. I also used to name two brands; I've removed those too. The same checklist is on the medicinal mushrooms guide.
Before you take it
If fatigue is the reason, the causes worth ruling out first, such as iron, thyroid, sleep and medicines, are ones your GP and a blood test can check. If liver enzymes or GGT are raised, see your GP before taking anything that acts on the liver, including reishi.
Book an Initial Consultation (£145) →Sources
- Tang W et al. A randomized, double-blind and placebo-controlled study of a Ganoderma lucidum polysaccharide extract in neurasthenia. J Med Food 2005;8:53–8. PMID 15857210, doi:10.1089/jmf.2005.8.53
- Zhao H et al. Spore powder of Ganoderma lucidum improves cancer-related fatigue in breast cancer patients undergoing endocrine therapy: a pilot clinical trial. Evid Based Complement Alternat Med 2012;2012:809614. PMID 22203880, doi:10.1155/2012/809614
- Jin X et al. Ganoderma lucidum (Reishi mushroom) for cancer treatment. Cochrane Database Syst Rev 2016;4:CD007731. PMID 27045603, doi:10.1002/14651858.CD007731.pub3
- Gao Y et al. Effects of Ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol Invest 2003;32:201–15. PMID 12916709, doi:10.1081/imm-120022979
- Gao Y et al. Effects of water-soluble Ganoderma lucidum polysaccharides on the immune functions of patients with advanced lung cancer. J Med Food 2005;8:159–68. PMID 16117607, doi:10.1089/jmf.2005.8.159
- Klupp NL et al. Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors. Cochrane Database Syst Rev 2015;2:CD007259. PMID 25686270, doi:10.1002/14651858.CD007259.pub2
- Cui XY et al. Extract of Ganoderma lucidum prolongs sleep time in rats. J Ethnopharmacol 2012;139:796–800. PMID 22207209, doi:10.1016/j.jep.2011.12.020
- Wachtel-Galor S et al. Ganoderma lucidum ('Lingzhi'); acute and short-term biomarker response to supplementation. Int J Food Sci Nutr 2004;55:75–83. PMID 14630595, doi:10.1080/09637480310001642510
- Yuen MF et al. Hepatotoxicity due to a formulation of Ganoderma lucidum (lingzhi). J Hepatol 2004;41:686–7. PMID 15464254, doi:10.1016/j.jhep.2004.06.016
- Wanmuang H et al. Fatal fulminant hepatitis associated with Ganoderma lucidum (Lingzhi) mushroom powder. J Med Assoc Thai 2007;90:179–81. PMID 17621752
- Guedikian R et al. Ganoderma lingzhi (Reishi mushroom)-induced acute liver injury in the setting of alcohol use. Cureus 2023;15:e45953. PMID 37885515, doi:10.7759/cureus.45953